P00747 (PLMN_HUMAN) Homo sapiens (Human)
Plasminogen UniProtKBInterProSTRINGInteractive Modelling
810 aa; Sequence (Fasta)
Available Structures
49 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE |
Heteromer P00779; | 99.6 | ||||
| CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX |
Heteromer P00779; | 99.6 | 2×SO4; | |||
| Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-su… |
Heteromer P15240; | 100.0 | 1×0GJ; | |||
| Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold … |
Heteromer Q4GWU5; | 100.0 | 2×SO4; | |||
| X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF MICROPLASMINOGEN WITH ALPHA DOMAIN OF STREPTOKINASE IN TH… |
Heteromer P00779; | 99.6 | 6×CD; | |||
| Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold … |
Heteromer Q4GWU5; | 100.0 | 1×SO4; 2×GOL; | |||
| Crystal structure of human microplasmin in complex with kazal-type inhibitor AaTI |
Heteromer Q177W0; | 100.0 | 1×GOL; 3×NA; | |||
| Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold … |
Heteromer Q4GWU5; | 100.0 | ||||
| Protease SFTI complex |
Heteromer Q4GWU5; | 99.59 | ||||
| Structure of plasmin and peptide complex |
Heteromer Q4GWU5; | 100.0 | 1×WMH; | |||
| Crystal structure of the plasmin-textilinin-1 complex |
Heteromer Q90WA1; | 100.0 | ||||
| The X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide… |
Heteromer P49054; | 100.0 | ||||
| The X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound a to a pepti… |
Heteromer P49054; | 100 | 1×DIO; | |||
| SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH1/AA] AND PLASMINOGEN KRINGLE 2 |
Heteromer P49054; | 92.86 | ||||
| SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH2/AA] AND PLASMINOGEN KRINGLE 2 |
Heteromer P49054; | 92.86 | ||||
| plasminogen binding group A streptococcal M protein |
Heteromer P49054; | 98.77 | 2×SO4; | |||
| STRUCTURE AND BINDING DETERMINANTS OF THE RECOMBINANT KRINGLE-2 DOMAIN OF HUMAN PLASMINOGEN TO AN I… |
Heteromer P49054; | 96.2 | ||||
| Solution structure of AGL55-Kringle 2 complex |
Heteromer M4I022; | 96.15 | ||||
| Solution structure of KTI55-Kringle 2 complex |
Heteromer M4I070; | 96.15 | ||||
| Y. pestis Plasminogen Activator Pla in Complex with Human Plasminogen Activation Loop Peptide ALP11 |
Heteromer P17811; | 100 | 4×MRD; 2×MPD; 1×C8E; 1×PO4; | |||
| STRUCTURE AND LIGAND DETERMINANTS OF THE RECOMBINANT KRINGLE 5 DOMAIN OF HUMAN PLASMINOGEN | homo-2-mer | 98.81 | ||||
| STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION | monomer | 100.0 | 1×NGA; 2×CL; | |||
| Human Plasminogen bound to streptococcal surface enolase | monomer | 100.0 | ||||
| The X-ray Crystal Structure of Full-Length type II Human Plasminogen | monomer | 100.0 | 1×NAG; 4×CL; 1×K; 1×BCT; 1×ACT; | |||
| The X-ray Crystal Structure of Full-Length type I Human Plasminogen | monomer | 100.0 | ||||
| The X-ray Structure of Human Angiostatin | monomer | 99.61 | 3×BCN; | |||
| Protease Inhibitor | monomer | 100.0 | 1×89M; | |||
| Protease Inhibitor | monomer | 100.0 | 1×89S; | |||
| Macrocyclic inhibitors targeting the prime site of the fibrinolytic serine protease plasmin | monomer | 100.0 | 1×A1AHR; | |||
| CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAIN | monomer | 99.59 | ||||
| Human PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT | monomer | 98.77 | 8×SO4; | |||
| CATALYTIC DOMAIN OF PLASMINOGEN | monomer | 98.78 | ||||
| Macrocyclic Plasmin Inhibitor | monomer | 99.58 | 1×GGI; 2×SO4; | |||
| Macrocyclic plasmin inhibitor | monomer | 99.59 | 1×M63; 1×SO4; | |||
| Macrocyclic plasmin inhibitor | monomer | 99.59 | 1×EUA; 3×SO4; | |||
| Macrocyclic plasmin inhibitor | monomer | 99.59 | 1×I5Y; 4×SO4; | |||
| Solution structure and functional characterization of human plasminogen kringle 5 | monomer | 98.8 | ||||
| Solution Structure of Human Plasminogen Kringle 3 | monomer | 98.8 | ||||
| KRINGLE 2 DOMAIN OF HUMAN PLASMINOGEN: NMR SOLUTION STRUCTURE OF TRANS-4-AMINOMETHYLCYCLOHEXANE-1-C… | monomer | 96.39 | 1×AMH; | |||
| plasminogen kringle 1 in complex with inhibitor | monomer | 100 | 1×XO3; | |||
| THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH… | monomer | 100 | 1×ACA; | |||
| THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH… | monomer | 100 | 1×AMH; | |||
| THE REFINED STRUCTURE OF THE EPSILON-AMINOCAPROIC ACID COMPLEX OF HUMAN PLASMINOGEN KRINGLE | monomer | 100 | 1×ACA; | |||
| THE STRUCTURE OF RECOMBINANT PLASMINOGEN KRINGLE 1 AND THE FIBRIN BINDING SITE | monomer | 100 | 2×CL; | |||
| STRUCTURE OF KRINGLE 4 AT 4C TEMPERATURE AND 1.67 ANGSTROMS RESOLUTION | monomer | 100 | 1×SO4; | |||
| CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 4 REFINED AT 1.9-ANGSTROMS RESOLUTION | monomer | 100 | 1×SO4; | |||
| SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACI… | monomer | 100 | ||||
| SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACI… | monomer | 100 | 1×ACA; | |||
| KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES | monomer | 100 | ||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4dur.2.A | monomer | 0.77 | 1×K; | 100.00 | ||
| 4duu.1.A | monomer | 0.75 | 100.00 | |||
| 4hzh.2.A | monomer | 0.57 | 35.33 | |||
| 9cln.1.D | monomer | 0.56 | 35.42 | |||
| 9cls.1.D | monomer | 0.51 | 36.84 | |||